Skip to main content
. 2017 Dec 7;2017:3941217. doi: 10.1155/2017/3941217

Figure 6.

Figure 6

Pooled analysis of the nonchemotherapy subgroup (abiraterone, enzalutamide, and sipuleucel-T). Hazard ratio is used to indicate differences in overall survival (OS) and progression-free survival, while risk ratio (RR) is used for PSA response and adverse events. An HR or RR < 1 favors that treatment group. First rank means superior outcome (excluding AEs). PSA: prostate-specific antigen. Indirect comparison.